Shares of The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $109.48.
COO has been the topic of several research reports. TheStreet downgraded shares of Cooper Companies from a “b-” rating to a “c” rating in a research report on Thursday, February 29th. JPMorgan Chase & Co. raised shares of Cooper Companies from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $100.00 to $120.00 in a research report on Wednesday, March 13th. Redburn Atlantic raised shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price objective on the stock in a research report on Tuesday, March 19th. Mizuho lifted their target price on shares of Cooper Companies from $102.50 to $115.00 and gave the company a “buy” rating in a report on Friday, March 1st. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $110.00 target price (up previously from $105.00) on shares of Cooper Companies in a report on Friday, March 1st.
View Our Latest Stock Report on Cooper Companies
Cooper Companies Price Performance
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings results on Thursday, February 29th. The medical device company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.78 by $0.07. Cooper Companies had a net margin of 7.93% and a return on equity of 8.79%. The firm had revenue of $931.60 million for the quarter, compared to analyst estimates of $915.93 million. During the same period last year, the business earned $2.90 EPS. Cooper Companies’s revenue for the quarter was up 8.5% compared to the same quarter last year. Equities analysts forecast that Cooper Companies will post 3.5 EPS for the current fiscal year.
Insider Activity
In other news, CAO Agostino Ricupati sold 54,724 shares of the company’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $100.89, for a total value of $5,521,104.36. Following the completion of the transaction, the chief accounting officer now directly owns 5,081 shares in the company, valued at $512,622.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CAO Agostino Ricupati sold 54,724 shares of the company’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $100.89, for a total value of $5,521,104.36. Following the sale, the chief accounting officer now directly owns 5,081 shares of the company’s stock, valued at $512,622.09. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gary S. Petersmeyer sold 1,000 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $103.51, for a total transaction of $103,510.00. Following the completion of the sale, the director now directly owns 5,668 shares in the company, valued at $586,694.68. The disclosure for this sale can be found here. Insiders own 2.00% of the company’s stock.
Institutional Trading of Cooper Companies
A number of large investors have recently modified their holdings of the company. Cary Street Partners Investment Advisory LLC bought a new position in shares of Cooper Companies during the 3rd quarter valued at about $26,000. KB Financial Partners LLC purchased a new stake in shares of Cooper Companies in the first quarter worth approximately $34,000. Clear Street Markets LLC lifted its position in shares of Cooper Companies by 93.9% in the first quarter. Clear Street Markets LLC now owns 95 shares of the medical device company’s stock worth $35,000 after purchasing an additional 46 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Cooper Companies by 54.8% in the fourth quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after purchasing an additional 34 shares in the last quarter. Finally, Mather Group LLC. bought a new position in Cooper Companies during the first quarter valued at approximately $41,000. Institutional investors and hedge funds own 24.39% of the company’s stock.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
- Five stocks we like better than Cooper Companies
- Market Cap Calculator: How to Calculate Market Cap
- 5 Trends You Need to Know This Quarter
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- MarketBeat Week in Review – 4/8 – 4/12
- How to Calculate Inflation Rate
- You Can Follow BlackRock’s Market View for Your Money
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.